Trial record 1 of 1 for:    GC P#02.01.001
Previous Study | Return to List | Next Study

Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy (ExCell)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Gamida Cell -Teva Joint Venture Ltd.
ClinicalTrials.gov Identifier:
NCT00469729
First received: May 3, 2007
Last updated: July 9, 2015
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2015
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)